Mary Beth Scholand

7.3k total citations
67 papers, 2.1k citations indexed

About

Mary Beth Scholand is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Pathology and Forensic Medicine. According to data from OpenAlex, Mary Beth Scholand has authored 67 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Pulmonary and Respiratory Medicine, 24 papers in Physiology and 15 papers in Pathology and Forensic Medicine. Recurrent topics in Mary Beth Scholand's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (39 papers), Sarcoidosis and Beryllium Toxicity Research (15 papers) and Systemic Sclerosis and Related Diseases (15 papers). Mary Beth Scholand is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (39 papers), Sarcoidosis and Beryllium Toxicity Research (15 papers) and Systemic Sclerosis and Related Diseases (15 papers). Mary Beth Scholand collaborates with scholars based in United States, United Kingdom and Saudi Arabia. Mary Beth Scholand's co-authors include Hilary Coon, Dale S. Cannon, William M. McMahon, Mark Leppert, Kevin R. Flaherty, James F. Gruden, Kevin O. Leslie, James M. Parish, Jonathan Goldin and Thomas B. Neff and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Mary Beth Scholand

59 papers receiving 2.0k citations

Peers

Countries citing papers authored by Mary Beth Scholand

Since Specialization

Citations

This map shows the geographic impact of Mary Beth Scholand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Beth Scholand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Beth Scholand more than expected).

Fields of papers citing papers by Mary Beth Scholand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Beth Scholand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Beth Scholand. The network helps show where Mary Beth Scholand may publish in the future.

Co-authorship network of co-authors of Mary Beth Scholand

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Beth Scholand. A scholar is included among the top collaborators of Mary Beth Scholand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Beth Scholand. Mary Beth Scholand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Multi-modal machine learning classifier for idiopathic pulmonary fibrosis predicts mortality in interstitial lung diseases 2025 ·Respiratory Investigation ·Sean J. Callahan, Mary Beth Scholand, (unknown), Michael Muelly, Joshua Reicher	1
2	Efficacy of a novel interstitial lung disease monitoring program in breast cancer patients undergoing treatment with trastuzumab-deruxtecan 2025 ·Breast Cancer Research and Treatment ·(unknown), (unknown), Mary Beth Scholand, (unknown), (unknown), Peter C. Jeppson, Holly E. Jacobson, Saundra S. Buys	0
3	Caring for Rural Patients With Interstitial Lung Disease 2025 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Rebecca Bascom, (unknown), Mary Beth Scholand, (unknown), Anoop M. Nambiar, Sonye K. Danoff, Franck Rahaghi, Tejaswini Kulkarni, (unknown)	0
4	Demographic and Clinical Factors Associated With Diagnostic Confidence in Interstitial Lung Disease 2024 ·SHILAP Revista de lepidopterología ·Mary Beth Scholand, (unknown), Kevin R. Flaherty, Rosalinda V. Ignacio, Zhongze Li, Ayodeji Adegunsoye	0
5	Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis: The INTEGRIS-IPF Clinical Trial 2024 ·American Journal of Respiratory and Critical Care Medicine ·Lisa Lancaster, Vincent Cottin, Murali Ramaswamy, Wim Wuyts, Gísli Jenkins, Mary Beth Scholand, Michael Kreuter, Claudia Valenzuela, Christopher J. Ryerson, Jonathan Goldin, Grace Hyun J. Kim, Marzena Jurek, Martin Decaris, (unknown), Scott Turner, Chris N. Barnes, Hardean E. Achneck, Gregory P. Cosgrove, Éric Lefebvre, Kevin R. Flaherty	35
6	Design of the STRIVE-IPF trial- study of therapeutic plasma exchange, rituximab, and intravenous immunoglobulin for acute exacerbations of idiopathic pulmonary fibrosis 2024 ·BMC Pulmonary Medicine ·Tejaswini Kulkarni, Gerard J. Criner, Daniel J. Kass, Iván O. Rosas, Mary Beth Scholand, Daniel F. Dilling, Ross Summer, Steven R. Duncan	9
7	Pulmonary hemodynamics and transplant‐free survival in sarcoidosis‐associated pulmonary hypertension: Results from an international registry 2023 ·Pulmonary Circulation ·(unknown), Robert P. Baughman, Steven D. Nathan, Athol U. Wells, Vasileios Kouranos, Esam H. Alhamad, Daniel A. Culver, Joseph B. Barney, (unknown), Francis Cordova, (unknown), Mary Beth Scholand, Marlies Wijsenbeek, Sivagini Ganesh, Surinder S. Birring, Laura Price, Stephen J. Wort, Oksana A. Shlobin, Rohit Gupta	10
8	A 64-Year-Old Man With Multifocal Infiltrates 2021 ·CHEST Journal ·(unknown), (unknown), Sean J. Callahan, Mary Beth Scholand	2
9	Development and Initial Validation Analyses of the Living with Idiopathic Pulmonary Fibrosis Questionnaire 2020 ·American Journal of Respiratory and Critical Care Medicine ·Jeffrey J. Swigris, David Andrae, (unknown), (unknown), Mary Beth Scholand, Eric S. White, (unknown), Karina Raimundo, Christopher J. Evans	28
10	Clinical phenotyping: role in treatment decisions in sarcoidosis 2020 ·European Respiratory Review ·Robert P. Baughman, Mary Beth Scholand, Franck Rahaghi	25
11	Patient Factors and Disease Severity Impact Cough-Specific Quality of Life in Patients with Interstitial Lung Disease 2019 ·(unknown), Mary Beth Scholand, Jason H. Moore, (unknown), Mary E. Strek, Anna J. Podolanczuk, N. Patel	0
12	Healthcare utilisation and costs in the diagnosis and treatment of progressive-fibrosing interstitial lung diseases 2018 ·European Respiratory Review ·Colin Holtze, Kevin R. Flaherty, Michael Kreuter, Fabrizio Luppi, Teng Moua, Carlo Vancheri, Mary Beth Scholand	18
13	Outcome Measures for Clinical Trials in Interstitial Lung Diseases 2015 ·Current Respiratory Medicine Reviews ·Matthew R. Lammi, Robert P. Baughman, Surinder S. Birring, Anne‐Marie Russell, Jay H. Ryu, Mary Beth Scholand, Oliver Distler, (unknown), Catherine Sarver, Κατερίνα Αντωνίου, Kristin B. Highland, Otylia Kowal‐Bielecka, Joseph A. Lasky, Athol U. Wells, Lesley Ann Saketkoo	32
14	The Vascular Microenvironment and Systemic Sclerosis 2010 ·International Journal of Rheumatology ·Tracy Frech, Nathan Hatton, Boaz A. Markewitz, Mary Beth Scholand, Richard Cawthon, Amit N. Patel, Allen D. Sawitzke	6
15	Hypercapnia Effect on Core Cooling and Shivering Threshold During Snow Burial 2008 ·Aviation Space and Environmental Medicine ·Colin K. Grissom, (unknown), Christopher Harmston, (unknown), Gordon G. Giesbrecht, Mary Beth Scholand, (unknown)	23
16	The PHQ-9 as a brief assessment of lifetime major depression. 2007 ·Psychological Assessment ·Dale S. Cannon, Stephen T. Tiffany, Hilary Coon, Mary Beth Scholand, William M. McMahon, Mark Leppert	98
17	Relationship of BMPR2 Mutations to Vasoreactivity in Pulmonary Arterial Hypertension 2006 ·Circulation ·C. Gregory Elliott, Eric W. Glissmeyer, (unknown), John F. Carlquist, Jason T. McKinney, Stuart Rich, Michael D. McGoon, Mary Beth Scholand, Miryoung Kim, Robert L. Jensen, (unknown), Kenneth Ward	110
18	Hypothermia During Avalanche Burial 2004 ·Colin K. Grissom, Christopher Harmston, (unknown), Mary Beth Scholand, (unknown), (unknown), (unknown), (unknown)	0
19	Clinical approach to interstitial lung disease 2002 ·Seminars in Ultrasound CT and MRI ·Mary Beth Scholand	1
20	Normal oxygenation and ventilation during snow burial by the exclusion of exhaled carbon dioxide☆ 2001 ·Wilderness and Environmental Medicine ·(unknown), Colin K. Grissom, Mary Beth Scholand, Christopher Harmston	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact